NORDDINE HABTI

Prof. Dr. NORDDINE HABTI

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2016 in BMC Immunology
Verified
Journal Article
Open access
PDF file
MMMouna Moutia
Mouna Moutia
KAKhadija El Azhary
Khadija El Azhary
AOAnass El ouaddari
Anass El ouaddari
AJAbdellah Al Jahid
Abdellah Al Jahid
JEJamal Jamal Eddine
Jamal Jamal Eddine
ABAbdallah Badou
Abdallah Badou
Capparis Spinosa L. is an aromatic plant growing wild in dry regions around the Mediterranean basin. Capparis Spinosa was shown to possess several properties such as antioxidant, antifungal, and anti-hepatotoxic actions. In this work, we aimed to evaluate immunomodulatory properties of Capparis Spinosa leaf extracts in vitro on human peripheral blood mononuclear cells (PBMCs) from healthy individuals. Using MTT assay, we identified a range of Capparis Spinosa doses, which were not toxic. Unexpectedly, we found out that Capparis Spinosa aqueous fraction exhibited an increase in cell metabolic activity, even though similar doses did not affect cell proliferation as shown by CFSE. Interestingly, Capparis Spinosa aqueous fraction appeared to induce an overall anti-inflammatory response through significant inhibition of IL-17 and induction of IL-4 gene expression when PBMCs were treated with the non toxic doses of 100 and/or 500 μg/ml. Phytoscreening analysis of the used Capparis Spinosa preparations showed that these contain tannins; sterols, alkaloids; polyphenols and flavonoids. Surprisingly, quantification assays showed that our Capparis Spinosa preparation contains low amounts of polyphenols relative to Capparis Spinosa used in other studies. This Capparis Spinosa also appeared to act as a weaker scavenging free radical agent as evidenced by DPPH radical scavenging test. Finally, polyphenolic compounds including catechin, caffeic acid, syringic acid, rutin and ferulic acid were identified by HPLC, in the Capparis spinosa preparation. Altogether, these findings suggest that our Capparis Spinosa preparation contains interesting compounds, which could be used to suppress IL-17 and to enhance IL-4 gene expression in certain inflammatory situations. Other studies are underway in order to identify the compound(s) underlying this effect.

31 January 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
KAKhadija El Azhary
Khadija El Azhary
NJNadia Tahiri Jouti
Nadia Tahiri Jouti
MKMeryam El Khachibi
Meryam El Khachibi
MMMouna Moutia
Mouna Moutia
ITImane Tabyaoui
Imane Tabyaoui
ABAbdallah Badou
Abdallah Badou
Several chronic inflammatory diseases are characterized by inappropriate CD4+ T cell response. In the present study, we assessed the ability of Capparis spinosa L. (CS) preparation to orientate, in vivo, the immune response mediated by CD4+ T cells towards an anti-inflammatory response. The in vivo study was carried out by using the contact hypersensitivity (CHS) model in Swiss mice. Then we performed a histological analysis followed by molecular study by using real time RT-PCR. We also realized a phytochemical screening and a liquid-liquid separation of CS preparation. Our study allowed us to detect a significantly reduced edema in mice treated with CS preparations relative to control. CS effect was dose dependent, statistically similar to that observed with indomethacin, independent of the plant genotype and of the period of treatment. Furthermore, our histology studies revealed that CS induced a significant decrease in immune cell infiltration, in vasodilatation and in dermis thickness in the inflammatory site. Interestingly, we showed that CS operated by inhibiting cytokine gene expression including IFNγ, IL-17 and IL-4. Besides, phytochemical screening of CS extract showed the presence of several chemical families such as saponins, flavonoids and alkaloids. One (hexane fraction) out of the three distinct prepared fractions, exhibited an anti-inflammatory effect similar to that of the raw preparation, and would likely contain the bioactive(s) molecule(s). Altogether, our data indicate that CS regulates inflammation induced in vivo in mice and thus could be a source of anti-inflammatory molecules, which could be used in some T lymphocyte-dependent inflammatory diseases.

30 May 2016 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
SZS. Zouine
S. Zouine
FMF. Marnissi
F. Marnissi
NON. Otmani
N. Otmani
MOM. Bennani Othmani
M. Bennani Othmani
MWM. El Wafi
M. El Wafi
NHNORDDINE HABTI
NORDDINE HABTI

3 January 2018 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
CHCheikh Tijani Hamed
Cheikh Tijani Hamed
GMGhlana Meiloud
Ghlana Meiloud
FVFatimetou Veten
Fatimetou Veten
MHMouna Hadrami
Mouna Hadrami
SGSidi M. Ghaber
Sidi M. Ghaber
AHAhmed Houmeida
Ahmed Houmeida
HLA antigens have been widely studied for their role in transplantation biology, human diseases and population diversity. The aim of this study was to provide the first profile of HLA class I and class II alleles in the Mauritanian population. HLA typing was carried in 93 healthy Mauritanian blood donors, using single specific primer amplification (PCR-SSP). Occurrences of the main HLA class I (-A, -B, -C) and class II (-DR, -DQ) antigens in the general population showed that out of the 17 HLA-A allele groups detected, five main HLA-A allele groups: A*02 (18.42%), A*01 (14.04%), A*23 (14.04%), A*30 (13.16%) and A*29 (12.28%) were the most common identified along other 12 relatively minor allele groups. Twenty three allele groups were observed in the locus B of which B*07 (13.46%) was the most prevalent followed by B*15, B*35, B*08 and B*27 all, with a frequency between 7 to 8%. Three prevalent HLA-C allele groups (C*02: 35.09%, C*07: 20.19% and C*06: 13.6%) were detected. The main HLA class II observed allele groups were: DRB1*13 (27.42%), DRB1*03 (24.73%), DRB1*11 (13.98%), DQB1*03 (36.03%), DQB1*02 (22.06%) and DQB1*05 (18.8%). Except for few haplotype in class I (A*02-B*07: 4.45%, A*02-C02: 10%, A*23-C*02: 8.8%, B*07-C*02: 8.8%, B*15-C*02: 8.8%) and in class II (DRB1*13-DQB1*06: 11.94%, DRB1*03-DQB1*02:11.19% and DRB1*03-DQB1*03: 10.45%), the majority of locus combination were in the range of 2–3%. A single predominant haplotype C*02-DRB1*03 (16.67%) was found. These results, in agreement with previous data using different tissues markers, underlined the ethnic heterogeneity of the Mauritanian population.

11 February 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
NANarjis Amar
Narjis Amar
ACAzeddine Chakroun
Azeddine Chakroun
HBHanane Ben-Taleb
Hanane Ben-Taleb
HSHind Sebbah
Hind Sebbah
ALAmine Lamrissi
Amine Lamrissi
MCMustapha Chamekh
Mustapha Chamekh
Background: Group B Streptococcus (GBS) is a commensal vaginal bacterium that can lead to adverse maternal and neonatal outcomes. In low or middle-income countries, few data are available regarding the immune-inflammatory response in GBS-colonized pregnant mothers and its association with the risk of neonatal invasive disease. In this investigation, we implement a prospective study on a cohort of mother–newborn dyads in Morocco to assess the cytokine profile in GBS-colonized-mothers whose newborns have invasive GBS disease. Methods: Pregnant women between 35 and 40 weeks of gestation were screened for vaginal colonization by GBS and followed up until delivery. A panel of inflammatory cytokines was quantified by Luminex multiplex assays and by ELISA in maternal and cord blood, as well as in supernatants after stimulation of pathogen recognition receptors. GBS-colonized-mothers were clustered according to clinical and inflammation markers and to their newborn's infection status. Results: GBS-colonized-mothers whose newborns developed invasive GBS disease exhibited significantly lower IL-1β, IL-4, and IL-17A production compared with GBS-colonized-mothers with healthy newborns. Similar results were obtained following ex vivo stimulation of peripheral blood cells by TLR4 and TLR1/2 ligands. The level of circulating maternal IL-17A had a higher significant predictive value for GBS transmission leading to invasive neonatal disease. Conclusions: This study shows that GBS-colonized-mothers may exhibit a greater cytokine inflammatory response compared with noncolonized-mothers. Regarding mother–newborn dyads, maternal IL-17A, a key mediator of antibacterial defense, emerges as a significant prognostic biomarker for assessing the risk of GBS transmission and the development of neonatal GBS invasive disease.

24 February 2016 in International Journal of Blood Transfusion and Immunohematology
Verified
Journal Article
Open access
PDF file
MWMariam EL Wafi
Mariam EL Wafi
HHHouria EL Housse
Houria EL Housse
NNNadia Nourichafi
Nadia Nourichafi
KBKamal Bouisk
Kamal Bouisk
MBMohamed Benajiba
Mohamed Benajiba
NHNORDDINE HABTI
NORDDINE HABTI
Aims: Determination of D variants is important for selection of blood products and to prevent anti-D-related hemolytic disease of the fetus and newborn. The prevalence of weak D phenotypes varies significantly among different ethnic populations. In Morocco, D variants have not been fully characterized. The purpose of this study was to determine prevalence of weak D among D negative and C/E+ blood donors and distribution of Rhesus blood group antigens using serologic methods. Methods: A total of 15,865 blood samples from Moroccan blood donors were tested for D, C, c, E, e antigens by routine serologic methods. Among blood donors serologically D negative C+ and/or E+, 63 samples were tested for weak D by indirect antiglobuline test, enzymatic treated cells test and adsorption elution technique. Results: Among 63 samples tested, 10 were positive by serologic methods (15.87%). Six samples identified as weak D by enzymatic test and four samples identified as Del by adsorption elution. Rhesus blood group antigens are distributed as DCcee: 38.85% and dccee :8.77%. Conclusion: The prevalence of D variants must be considered in transfusional and obstetrical strategy for RhD typing to ensure blood transfusion safety by optimizing the management of D-negative RBC units and Rh immune globulins.